Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.17 | 0.2 |
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |